DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,023,726 | -10.1% | 2,935,919 | -12.5% | 0.00% | 0.0% |
| Q2 2023 | $40,050,652 | +32.7% | 3,354,326 | +48.6% | 0.00% | 0.0% |
| Q1 2023 | $30,173,296 | -71.5% | 2,256,791 | -54.1% | 0.00% | -33.3% |
| Q4 2022 | $105,729,266 | +158.5% | 4,913,070 | +140.6% | 0.00% | 0.0% |
| Q3 2022 | $40,896,000 | +536.8% | 2,041,738 | +469.1% | 0.00% | – |
| Q2 2022 | $6,422,000 | +199.4% | 358,783 | +65.9% | 0.00% | – |
| Q1 2022 | $2,145,000 | -32.8% | 216,216 | +14.1% | 0.00% | – |
| Q4 2021 | $3,193,000 | +8.5% | 189,491 | +52.8% | 0.00% | – |
| Q3 2021 | $2,943,000 | – | 124,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |